Abstract:Background. Chronic kidney disease (CKD) is a common cause of morbidity and mortality in human immunodeficiency virus (HIV)-positive individuals. Among the HIV-related kidney diseases, HIV-associated nephropathy (HIVAN) is a rapidly progressive renal disease characterized by collapsing focal glomerulosclerosis (GS), microcystic tubular dilation, interstitial inflammation and fibrosis. Although the incidence of end-stage renal disease due to HIVAN has dramatically decreased with the widespread use of antiretroviral therapy, the prevalence of CKD continues to increase in HIV-positive individuals. Recent studies have highlighted the role of apoptosis signal-regulating kinase 1 (ASK1) in driving kidney disease progression through the activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase and selective ASK-1 inhibitor GS-444217 was recently shown to reduce kidney injury and disease progression in various experimental models. Therefore we examined the efficacy of ASK1 antagonism by GS-444217 in the attenuation of HIVAN in Tg26 mice. Methods. GS-444217-supplemented rodent chow was administered in Tg26 mice at 4weeks of age when mild GS and proteinuria were already established. After 6weeks of treatment, the kidney function assessment and histological analyses were performed and compared between age- and gender-matched control Tg26 and GS-444217-treated Tg26 mice. Results. GS-444217 attenuated the development of GS, podocyte loss, tubular injury, interstitial inflammation and renal fibrosis in Tg26 mice. These improvements were accompanied by a marked reduction in albuminuria and improved renal function. Taken together, GS-4442217 attenuated the full spectrum of HIVAN pathology in Tg26 mice. Conclusions. ASK1 signaling cascade is central to the development of HIVAN in Tg26 mice. Our results suggest that the select inhibition of ASK1 could be a potential adjunctive therapy for the treatment of HIVAN.

PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy

PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy

Activation of NRF2 Blocks HIV Replication and Apoptosis in Macrophages

Inhibition of Apoptosis Signal-Regulating Kinase 1 Mitigates the Pathogenesis of Human Immunodeficiency Virus-Associated Nephropathy.

Upregulation of expression of platelet-derived growth factor and its receptor in pneumonia associated with SHIV-infected macaques.

NAD deficiency contributes to progressive kidney disease in HIV nephropathy mice

Role of SIRT1 in HIV-associated Kidney Disease.

Role of the Retinoic Acid Receptor-Α in HIV-associated Nephropathy

Low Expression of HIV Genes in Podocytes Accelerates the Progression of Diabetic Kidney Disease in Mice.

Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury

Tubular-specific Expression of HIV Protein Vpr Leads to Severe Tubulointerstitial Damage Accompanied by Progressive Fibrosis and Cystic Development

A High Throughput RNAi Screen Reveals Determinants of HIV-1 Activity in Host Kinases.

HIV protease inhibitor lopinavir-induced TNF-α and IL-6 expression is coupled to the unfolded protein response and ERK signaling pathways in macrophages

A Systems Approach Identifies HIPK2 As a Key Regulator of Kidney Fibrosis

Deletion Of Podocyte Stat3 Mitigates The Entire Spectrum Of Hiv-1-Associated Nephropathy

HIV-1 Downregulates the Expression and Phosphorylation of Receptor Tyrosine Kinase by Targeting the NF-κB Pathway

Notch3 deletion regulates HIV-1 gene expression and systemic inflammation to ameliorate chronic kidney disease

Sirolimus Modulates HIVAN Phenotype Through Inhibition of Epithelial Mesenchymal Transition.

Constitutive Activation of Phosphatidylinositol 3-Kinase Signaling Pathway Down-regulates TLR4-mediated Tumor Necrosis Factor-α Release in Alveolar Macrophages from Asymptomatic HIV-positive Persons in Vitro

Temporal Profile of the Renal Transcriptome of HIV-1 Transgenic Mice During Disease Progression.

Modulation of Renin Angiotensin System Predominantly Alters Sclerotic Phenotype of Glomeruli in HIVAN.